K191728 is an FDA 510(k) clearance for the ULTepap Expiratory Positive Airway Pressure (EPAP) Device. This device is classified as a Expiratory Resistance Valve, Intranasal, For Obstructive Sleep Apnea (Class II - Special Controls, product code OHP).
Submitted by Bryggs Medical, LLC (Avon, US). The FDA issued a Cleared decision on February 21, 2020, 239 days after receiving the submission on June 27, 2019.
This device falls under the Anesthesiology FDA review panel. Regulated under 21 CFR 872.5570. Intranasal Device That Creates Expiratory Resistance For The Treatment Of Obstructive Sleep Apnea..